Ilant Health founder and CEO Elina Onitskansky, alongside Bryan Sivak (former HHS CTO), just published an op-ed in Fortune tackling a binary problem in the GLP-1 debate: cover everything, or cover nothing
If a fluoroquinolone is prescribed, heightened vigilance regarding blood glucose levels is essential
No, not everyone experiences side effects, though clinical trials show that most people will have some symptoms
Semaglutide has a 7-day half-life, and it takes approximately 5 weeks for 97% elimination
This can recalibrate expectations and help microdosers understand that while their approach minimizes side effects, it also significantly extends the timeline to therapeutic levels
Gastrointestinal effects are the most common adverse reactions, occurring in 2050% of patients depending on the specific agent and dose